Dogwood Therapeutics, Inc. (DWTX)
NASDAQ: DWTX · Real-Time Price · USD
1.230
-0.010 (-0.81%)
At close: Oct 29, 2026, 4:00 PM EDT
1.230
0.00 (0.00%)
Pre-market: Oct 30, 2026, 6:12 AM EDT
Dogwood Therapeutics Market Cap
Dogwood Therapeutics has a market cap or net worth of $41.81 million as of October 29, 2026. It is the 31,363rd most valuable company in the world and the 4,729th biggest in the United States. Its market cap has increased by 190.33% in one year.
Market Cap
41.81M
Enterprise Value
32.33M
1-Year Change
190.33%
Global Rank
Country Rank
#4,729 United States
Category
ChartMarket Cap Chart
Since December 17, 2020, Dogwood Therapeutics's market cap has decreased from $130.88M to $41.81M, a decrease of -68.05%. That is a compound annual growth rate of -17.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 41.81M | -66.19% |
| Dec 31, 2025 | 123.67M | 3,628.17% |
| Dec 31, 2024 | 3.32M | -70.04% |
| Dec 29, 2023 | 11.07M | 155.97% |
| Dec 30, 2022 | 4.33M | -89.85% |
| Dec 31, 2021 | 42.61M | -27.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Apollomics | 43.86M |
| Annovis Bio | 43.46M |
| Actinium Pharmaceuticals | 43.39M |
| INmune Bio | 42.46M |
| Grace Therapeutics | 42.28M |
| Serina Therapeutics | 41.66M |
| Aldeyra Therapeutics | 41.24M |
| Adicet Bio | 41.01M |